(PWRM, ZUMZ, URBN, PCBC, CLNO) Notable Stock by Stock-PR.com
Seeking Alpha Analyst Since 2011
FREE Daily Stock Alerts From Stock-PR.com
Power 3 Medical Products Inc. (OTC:PWRM)
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroProÂ®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
Alzheimer's disease was first identified in 1906 by a German psychiatrist and neuroanatomist named Alois Alzheimer. He was studying slides prepared from the brain of a fifty-one-year-old woman, known as Frau D., who had died after several years of dementia with symptoms that did not fit the definition of any brain disorder known at the time. Alzheimer was the first to describe the plaques and neurofibrillary tangles that are now used to identify AD at autopsy. Plaques are clumps or clusters of dead or dying nerve cells and other cellular debris found in the brains of patients with Alzheimer's disease. Neurofibrillary tangles are the accumulations of twisted protein fragments found inside the nerve cells in the brains of Alzheimer's patients.
Because dementia had been associated with elderly people and Frau D. had been middle-aged, AD was first known as presenile dementia and was thought to be a very rare disorder. It was not until the early 1950s that researchers at St. Elizabeth's Hospital in Washington, DC, came to recognize that AD is the single most common cause of dementia in adults.
The NuroPro Blood Test of Power3 Medical Products, Inc is a diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases would allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.
For more information about Power3 Medical Products, Inc., please visit http://www.power3medical.com
Zumiez, Inc. (Nasdaq:ZUMZ) reported results for the first quarter ended April 30, 2011. Total net sales for the first quarter (13 weeks) ended April 30, 2011 increased 18.8% to $105.9 million from $89.1 million reported in the first quarter ended May 1, 2010 (13 weeks). Comparable store sales for the first quarter of fiscal 2011 increased 12.6% on top of an increase of 9.1% for the first quarter of fiscal 2010. The Company posted net income for the quarter of $1.9 million or $0.06 per diluted share compared to a net loss of $1.9 million or ($0.06) per diluted share in the first quarter of the prior fiscal year. The results for the first quarter of fiscal 2010 include costs of approximately $1.2 million, or $0.03 per diluted share, associated with the relocation of the Company's distribution center from Everett, Washington to Corona, California.
Zumiez Inc. operates as a specialty retailer of action sports related apparel, footwear, equipment, and accessories in the United States. umiez Inc. was founded in 1978 and is based in Everett, Washington.
Urban Outfitters Inc. (Nasdaq:URBN) announced net income of $39 million or earnings per diluted share of $0.23 for the three months ended April 30, 2011. Total Company net sales rose by 9% over the same quarter last year to $524 million. Comparable retail segment net sales, which include our direct-to-consumer channels, decreased 1% for the quarter while comparable store net sales decreased 5% for the quarter. Comparable retail segment net sales at Free People and Urban Outfitters increased 30%, and 1%, respectively, while comparable retail segment net sales at Anthropologie decreased 6% for the quarter. Direct-to-consumer comparable net sales increased 15% and wholesale segment net sales rose 22% for the quarter.
Urban Outfitters, Inc. operates lifestyle specialty retail stores under the Urban Outfitters, Anthropologie, Free People, Terrain, Leifsdottir, and BHLDN brands. It also engages in wholesale business under the Free People and Leifsdottir brands.
Pacific Capital Bancorp (Nasdaq:PCBC) announced that it has changed the name of its national banking subsidiary from Pacific Capital Bank, National Association, to Santa Barbara Bank & Trust, National Association. This name change does not affect the name of the holding company, which remains Pacific Capital Bancorp.
Pacific Capital Bancorp operates as the holding company for Pacific Capital Bank, N.A., which provides a range of commercial and consumer banking services to households, professionals, and businesses primarily in the central coast of California.
Cleantech Transit Inc. (OTCPK:CLNO)
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects that could maximize shareholder value.
Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech Transit Inc. has selected to invest in Phoenix Energy (www.phoenixenergy.net).
Biomass energy as the name signifies is renewable or alternate energy derived from natural resources. The natural resources like agricultural wastes, tree leaves falls etc. The types of renewable source of energy includes biomass, wind, solar, water and geothermal. Some Biomass Energy Facts:
1. Biomass elements include leaves, grass, husks, wood chips, sugarcane fiber, sewage and many more agricultural products.
2. It is an alternate form of energy and available in huge amount around our society. Scientists are working hard to get more resourceful ways of using biomass energy as it has huge benefits compare to fossil fuels.
3. Biomass energy produces almost no sulfur emissions, and helps mitigate acid rain.
Cleantech Transit Inc. recently announced that the previously announced 500 KW biomass gasification facility located in Merced, California has successfully passed its interconnection tests and is now connected to the utility distribution grid.
The gasification technology uses a non-combustion process to convert Ag and other woody residues into a hydrogen rich gas ("syngas"), which is then converted into electricity, along with heat and biochar (a useful byproduct that captures carbon in solid form and can be used as a soil amendment).
The Phoenix Energy technology used in Merced essentially cooks the biomass in an oxygen-deprived environment to release the elemental gasses from the wood. In the process biomass is converted into a carbon rich biochar. With the carbon fixed in solid form this process not only provides a valuable soil amendment but also serves as a source of carbon sequestration.
The Merced plant is expected to produce enough electricity to power about 400 homes. The plant connected to the electricity grid under California's feed-in-tariff with a 15-year power purchase agreement.
For more information about CLNO, visit www.cleantechtransitinc.com
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM). Crown Equity Holdings Inc. (OTCPK:CRWE) anticipates receiving 5,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services for Cleantech Transit, Inc. (OTCPK:CLNO).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.